Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioQ, Sophos Partner for Post-Operative Pain Management Therapy | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioQ, Sophos Partner for Post-Operative Pain Management Therapy

The ready-to-use Ropivacaine product is a self-contained drug and administration system

By: Betsy Louda

, Contract Pharma

BioQ Pharma Incorporated and Sophos Biotech, both specialty pharmaceutical companies, have entered a strategic partnership agreement in Italy, under which BioQ will supply and Sophos will commercialize a treatment for post-operative pain management.

 

The 48-hour post-surgical pain management therapy is a disposable, single-use infusion system, which is pre-filled at the point of manufacture with 0.2% Ropivacaine (a non-narcotic local anesthetic). The ready-to-use product is activated by a single touch and contains a unit-dose of the sterile drug.

 

“We are delighted to announce this new partnership with Sophos, an aggressive and nimble player in the Italian market,” said Josh Kriesel, President and CEO of BioQ Pharma. “Sophos’ experienced management team will be essential to our future success in this important European market”.  

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters